Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine MB Yilmaz, K Yalta, C Yontar, F Karadas, A Erdem, OO Turgut, A Yilmaz, ... Cardiovascular Drugs and Therapy 21, 431-435, 2007 | 132 | 2007 |
Sleep quality among relatively younger patients with initial diagnosis of hypertension: Dippers versus non‐dippers MB Yilmaz, K Yalta, OO Turgut, A Yilmaz, O Yucel, G Bektasoglu, ... Blood pressure 16 (2), 101-105, 2007 | 109 | 2007 |
Tortuosity of coronary arteries: an indicator for impaired left ventricular relaxation? O Turgut, A Yilmaz, K Yalta, BM Yilmaz, A Ozyol, O Kendirlioglu, ... The international journal of cardiovascular imaging 23, 671-677, 2007 | 98 | 2007 |
Gamma-glutamyltransferase to determine cardiovascular risk: shifting the paradigm forward O Turgut, I Tandogan Journal of atherosclerosis and thrombosis 18 (3), 177-181, 2011 | 96 | 2011 |
Effect of sacubitril/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved … B Pieske, R Wachter, SJ Shah, A Baldridge, P Szeczoedy, G Ibram, V Shi, ... Jama 326 (19), 1919-1929, 2021 | 89 | 2021 |
Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure MB Yilmaz, C Yontar, A Erdem, F Karadas, K Yalta, OO Turgut, A Yilmaz, ... Heart and vessels 24, 16-21, 2009 | 89 | 2009 |
γ-Glutamyltransferase is a promising biomarker for cardiovascular risk O Turgut, A Yilmaz, K Yalta, F Karadas, MB Yilmaz Medical hypotheses 67 (5), 1060-1064, 2006 | 79 | 2006 |
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC‐HF baseline characteristics and comparison with contemporary clinical trials JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ... European journal of heart failure 22 (11), 2160-2171, 2020 | 55 | 2020 |
Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol MB Yilmaz, A Erdem, K Yalta, OO Turgut, A Yilmaz, I Tandogan Advances in therapy 25, 871-883, 2008 | 50 | 2008 |
Clinical importance of elevated CK-MB and troponin I levels in congestive heart failure A Yilmaz, K Yalta, OO Turgut, MB Yilmaz, A Ozyol, O Kendirlioglu, ... Advances in therapy 23, 1060-1067, 2006 | 39 | 2006 |
CA125 levels among patients with advanced heart failure: an emerging independent predictor for survival O Turgut, I Tandogan, MB Yilmaz, I Gul, A Gurlek International journal of cardiology 145 (1), 71, 2010 | 38 | 2010 |
Herbals in cardiovascular practice: are physicians neglecting anything? MB Yilmaz, OC Yontar, OO Turgut, A Yilmaz, K Yalta, M Gul, I Tandogan International journal of cardiology 122 (1), 48-51, 2007 | 36 | 2007 |
Avicenna: messages from a great pioneer of ancient medicine for modern cardiology O Turgut, S Manduz, I Tandogan International journal of cardiology 145 (2), 222, 2010 | 29 | 2010 |
Association of P wave duration and dispersion with the risk for atrial fibrillation: practical considerations in the setting of coronary artery disease O Turgut, I Tandogan, MB Yilmaz, K Yalta, O Aydin International journal of cardiology 144 (2), 322-324, 2010 | 29 | 2010 |
Evaluation of tumor markers CA-125 and CEA in acute myocardial infarction K Yalta, A Yilmaz, OO Turgut, T Erselcan, MB Yilmaz, F Karadas, C Yontar, ... Advances in therapy 23, 1052-1059, 2006 | 29 | 2006 |
Cancer antigen 125 levels and increased risk of new-onset atrial fibrillation. H Yucel, H Kaya, A Zorlu, K Yıldırımlı, E Sancakdar, H Gunes, R Kurt, ... Herz 40, 119-124, 2014 | 25 | 2014 |
Atrial fibrillation is associated with increased mean platelet volume in patients with type 2 diabetes mellitus O Turgut, A Zorlu, F Kilicli, Z Cinar, H Yucel, I Tandogan, HS Dokmetas Platelets 24 (6), 493-497, 2013 | 24 | 2013 |
Acute effects of passive smoking on endothelial function İ Gül, H Karapınar, M Yarlıoğlueş, I Ozdogru, MG Kaya, A Yılmaz, ... Angiology 62 (3), 245-247, 2011 | 24 | 2011 |
Association of γ-glutamyltransferase with cardiovascular risk: a prognostic outlook O Turgut, I Tandogan, A Gurlek Archives of medical research 40 (4), 318-320, 2009 | 24 | 2009 |
Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid? O Beton, E Saricam, H Kaya, H Yucel, O Dogdu, OO Turgut, O Berkan, ... BMC Cardiovascular Disorders 16, 1-10, 2016 | 23 | 2016 |